Companies › LFCR
LIFECORE BIOMEDICAL INC (LFCR)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001005286 · EDGAR filings · Updated 2026-07-02
LIFECORE BIOMEDICAL INC (LFCR) has reported institutional ownership of 67.0%, with 105 institutional managers holding positions valued at $112.3M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-02 — SCHEDULE 13D/A filed
- 2026-07-02 — Current report (8-K) filed
- 2026-07-02 — SCHEDULE 13D/A filed
- 2026-06-08 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
- 2026-06-05 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, LIFECORE BIOMEDICAL INC has 105 institutional holders and institutional ownership of 67.0%.
Insider activity
Insiders reported 29 transactions (0 buys, 10 sells) across 14 reporting insiders, with a net reported value of −$9.86M.
Data flags from SEC filings
Related companies
AIRSCULPT TECHNOLOGIES INC (AIRS) · CYBIN INC (HELP) · Onkure Therapeutics Inc (OKUR) · SHOULDER INNOVATIONS INC (SI) · ACUMEN PHARMACEUTICALS INC (ABOS) · ARTIVA BIOTHERAPEUTICS INC (ARTV)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.